Expression of opioid receptors during heart ontogeny in normotensive and hypertensive rats

Circulation

Volumn 93, Issue 5, 1996, Pages 1020-1025

  Zimlichman, Reuven ^a   Gefel, Dov ^a   Eliahou, Heskel ^a   Matas, Zipora ^a   Rosen, Boaz ^a   Gass, Svetlana ^b   Ela, Catherine ^c   Eilam, Yael ^c   Vogel, Zvi ^d   Barg, Jacob ^b,d,e  

^a TEL AVIV UNIVERSITY   (Israel)

^b WOLFSON MEDICAL CENTER   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^e Therapeutic Community Ramot Yehuda   (Israel)

Author keywords

cardiomyocytes, cultured; hypertension; receptors opioid

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; DELTA OPIATE RECEPTOR; DIPRENORPHINE; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; GUANINE NUCLEOTIDE BINDING PROTEIN; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; OPIATE AGONIST; PERTUSSIS TOXIN; TRITIUM;

ANALGESIA; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG BINDING SITE; DRUG RECEPTOR BINDING; HEART FUNCTION; HEART MUSCLE CELL; HYPERTENSION; NONHUMAN; ONTOGENY; PAIN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 9044247064     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.5.1020     Document Type: Article

References (39)

1. Dickenson AH. Mechanisms of the analgesic actions of opiates and opioids. Br Med Bull. 1991;47:690-702.
2. Skibsted L, Lange AP. The need for pain relief in uncomplicated deliveries in an alternative birth center compared to an obstetric delivery ward. Pain. 1992;48:183-186.
3. Grossman SA. Undertreatment of cancer pain: barriers and remedies. Support Care Cancer. 1993;1:74-78.
4. Bates ER. Treatment of acute myocardial infarction: a cardiologist's perspective. Int Anesthesiol Clin. 1992;30:237-250.
5. Kasper E, Ventura C, Ziman BD, Lakatta EG, Weisman H, Capogrossi MC. Effect of U-50488H on the contractile response of cardiomyopathic hamster ventricular myocytes. Life Sci. 1992;50: 2029-2035.
6. Millington WR, Evans VR, Forman LJ, Battie CN. Characterization of β-endorphin- and α-MSH-related peptides in rat heart. Peptides. 1993;14:1141-1147.
7. Wang JQ, Ingenito AJ. Comparative effects of intrahippocampal injection of dynorphin A(1-8), dynorphin A(1-13), dynorphin A(1-17), U-50488H, and dynorphin B on blood pressure and heart rate in spontaneously hypertensive and normotensive Wistar-Kyoto rats. Peptides. 1994;15:125-132.
8. Barg J, Levy R, Simantov R. Expression of the three opioid receptor subtypes μ, δ and κ in guinea pig and rat brain cell cultures and in vivo. Int J Dev Neurosci. 1989;7:173-179.
9. Barg J, Simantov R. Developmental profile of κ-, δ- and μ-opioid receptors in the rat and guinea pig cerebellum. Dev Neurosci. 1989; 11:428-434.
10. Barg J, Rius RA, Bern WT, Loh YP, Coscia CJ. Differential development of β-endorphin and μ-opioid-binding sites in mouse brain. Dev Brain Res. 1991;66:71-76.
11. Spain JW, Roth BL, Coscia CJ. Differential ontogeny of multiple opioid receptors (μ, δ, and κ). J Neurosci. 1985;5:584-588.
12. Himura Y, Liang CS, Imai N, Delehanty JM, Woolf PD, Hood WB Jr. Short-term effects of naloxone on hemodynamics and baroreflex function in conscious dogs with pacing-induced congestive heart failure. J Am Coll Cardiol. 1994;23:194-200.
13. Imai N, Kashiki M, Woolf PD, Liang CS. Comparison of cardiovascular effects of μ- and δ-opioid receptor antagonists in dogs with congestive heart failure. Am J Physiol. 1994;267:H912-H917.
14. Collins HL, DiCarlo SE. Attenuation of postexertional hypotension by cardiac afferent blockade. Am J Physiol. 1993;265:H1179-H1183.
15. Wu JP, Chen YT, Lee AY. Opioids in myocardial ischaemia: potentiating effects of dynorphin on ischaemic arrhythmia, bradycardia and cardiogenic shock following coronary artery occlusion in the rat. Eur Heart J. 1993;14:1273-1277.
16. Hochman I, Shaltiel C, Oppenheimer E, Same Y. Antiarrhythmic effect of naloxone and derivatives on ouabain-induced cardiac arrhythmias in cats. Pharmacol Commun. 1993;2:271-276.
17. Zhan Z, Lee AYS, Wong TM. Naloxone blocks the cardiac effects of myocardial ischemia and reperfusion in the rat isolated heart. Clin Exp Pharmacol Physiol. 1985;12:373-378.
18. Huang O, Zhan Y. Naloxone inhibits arrhythmias induced by coronary artery occlusion and reperfusion in anaesthetized dogs. Br J Pharmacol. 1986;87:475-477.
19. Tsai HF, Kuo TB, Chan JY, Chan SH. Interaction between neuronal responses to nociception and hypertension in the nucleus reticularis gigantocellularis of the rat. Neurosci Lett. 1994;165: 137-140.
20. Dworkin BR, Elbert T, Rau H, Birbaumer N, Pauli P, Droste C, Brunia CH. Central effects of baroreceptor activation in humans: attenuation of skeletal reflexes and pain perception. Proc Natl Acad Sci U S A. 1994;91:6329-6333.
21. Kardos A, Rau H, Greenlee MW, Droste C, Brody S, Roskamm H. Reduced pain during baroreceptor stimulation in patients with symptomatic and silent myocardial ischaemia. Cardiovasc Res. 1994; 28:515-518.
22. Zamir N, Segal M. Hypertension-induced analgesia: changes in pain sensitivity in experimental hypertensive rats. Brain Res. 1979; 244:295-303.
23. 2+ release from an intracellular pool in myocytes and neurons. Circ Res. 1992;70:66-81.
24. Tai KK, Bian CF, Wong TM. κ-Oproid receptor stimulation increases intracellular free calcium in isolated rat ventricular myocytes. Life Sci. 1992;51:909-913.
25. Springhorn JP, Claycomb WC. Preproenkephalin mRNA expression in developing rat heart and in cultured ventricular cardiac muscle cells. Biochem J. 1989;258:73-78.
26. Barron BA, Gu H, Gaugl JF, Caffrey JL. Screening for opioids in dog heart. J Mol Cell Cardiol. 1992;24:67-77.
27. 4 formation in adult cultured rat ventricular cardiomyocytes. Biochem Biophys Res Commun. 1991;179:972-978.
28. ++ influx and beating rate in cultured cardiac myocytes. J Pharmacol Exp Ther. 1994;269:1300-1309.
29. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with folin phenol reagent. J Biol Chem. 1951;193:265-275.
30. Vogel Z, Barg J, Levy R, Saya D, Heldman E, Mechoulam R. Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J Neurochem. 1993;61:352-355.
31. Vogel Z, Nah S-Y, Saya D, Levy R, Attali B, Barg J. Signal transduction of opiate receptors in spinal cord cells. J Toxicol-Toxin Rev. 1994;13:115-123.
32. Attali B, Saya D, Vogel Z. κ-Opiate agonists inhibit adenylate cyclase and produce heterologous desensitization in rat spinal cord. J Neurochem. 1989;52:360-369.
33. Thomas JM, Hoffman BB. Buprenorphine prevents and reverses the expression of chronic etorphine-induced sensitization of adenylyl cyclase in SK-N-SH human neuroblastoma cells. J Pharmacol Exp Ther. 1993;264:368-374.
34. Attali B, Saya D, Vogel Z. Pre- and postnatal development of opiate receptor subtypes in rat spinal cord. Dev Brain Res. 1990;53: 97-102.
35. 2+ influx in rat spinal cord-dorsal root ganglion cocultures: involvement of a GTP-bindina protein. J Biol Chem. 1989;264: 347-353.
36. Rosa C, Vignocchi G, Panattoni E, Rossi B, Ghione S. Relationship between increased blood pressure and hypoalgesia: additional evidence for the existence of an abnormality of pain perception in arterial hypertension in humans. J Hum Hypertens. 1994;8:119-126.
37. Feuerstein G, Siren AL. The opioid peptides: a role in hypertension? Hypertension. 1987;9:561-565.
38. Reddy SVR, Maderdrut JL, Yakash TL. Spinal cord pharmacology of adrenergic agonist-mediated antinociception. J Pharmacol Exp Ther. 1980;213:525-533.
39. Rizzoni D, Castellano M, Porteri E, Bettoni G, Muiesan ML, Agabiti-Rosi E. Vascular structural and functional alterations before and after the development of hypertension in SHR. Am J Hypertens. 1994;7:193-200.